Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
    • Publication Information:
      Original Publication: Oxford : Wiley-Blackwell
    • Subject Terms:
      Atrial Fibrillation*/diagnosis ; Atrial Fibrillation*/epidemiology ; Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/epidemiology ; Glucose Intolerance*/diagnosis ; Glucose Intolerance*/epidemiology; Humans ; Male ; New Zealand/epidemiology ; Female
    • Abstract:
      Background The association between the onset of type 2 diabetes (T2D) and atrial fibrillation (AF) risk in individuals with impaired glucose tolerance (IGT) remains unclear. This study aimed to investigate the relationship between the incident onset of T2D and 5- and 10-year (after the landmark period) risks of AF in people with IGT identified in South and West Auckland primary care settings between 1994 and 2019. Methods and Results We compared AF risk in patients with IGT with and without newly diagnosed T2D within a 1- to 5-year exposure window. Tapered matching and landmark analysis (to address immortal bias) were used to control for confounding variables. The cohorts incorporated 785 patients who had T2D newly diagnosed within 5 years from enrollment (landmark date) and 15 079 patients without a T2D diagnosis. Patients progressing to T2D exhibited significantly higher 5-year (after the landmark period) AF risk (hazard ratio [HR], 1.34 [95% CI, 1.10-1.63]) and 10-year (after the landmark period) AF risk (HR, 1.28 [95% CI, 1.02-1.62]) compared with those without incident T2D. The association was more pronounced among men, older patients, socioeconomically deprived individuals, current smokers, those with higher metabolic measures, and lower renal function. New Zealand European ethnicity was associated with a lower 5- and 10-year risk of AF. Conclusions This study found a mediating effect of T2D on the risk of AF in a population with IGT in New Zealand. The development of risk scores and future replication studies can help identify and guide management of individuals with IGT at the highest risk of AF following incident T2D.
    • References:
      Ann Intern Med. 2004 Sep 21;141(6):421-31. (PMID: 15381515)
      BMJ. 2020 Jul 15;370:m2297. (PMID: 32669282)
      Am Heart J. 2013 Nov;166(5):935-40.e1. (PMID: 24176451)
      J Diabetes Complications. 2018 May;32(5):501-511. (PMID: 29653902)
      Heart. 2012 Jan;98(2):133-8. (PMID: 21930722)
      N Z Med J. 2006 Jun 02;119(1235):U1997. (PMID: 16751821)
      JAMA. 2004 Nov 24;292(20):2471-7. (PMID: 15562125)
      Stroke. 2013 Apr;44(4):961-7. (PMID: 23471272)
      Circ Cardiovasc Qual Outcomes. 2011 May;4(3):363-71. (PMID: 21586725)
      Circulation. 2014 Feb 25;129(8):837-47. (PMID: 24345399)
      Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. (PMID: 29222373)
      N Z Med J. 1997 Feb 28;110(1038):48-50. (PMID: 9076284)
      N Z Med J. 1999 Sep 24;112(1096):361-3. (PMID: 10587056)
      Lancet Glob Health. 2021 Feb;9(2):e209-e217. (PMID: 33069275)
      JAMA. 2008 Dec 3;300(21):2489-96. (PMID: 19050192)
      Osteoarthritis Cartilage. 2015 May;23(5):803-14. (PMID: 25952351)
      Arch Intern Med. 2012 May 14;172(9):739-41. (PMID: 22782205)
      Stat Med. 2011 Feb 20;30(4):377-99. (PMID: 21225900)
      Cardiovasc Diabetol. 2021 Dec 24;20(1):241. (PMID: 34952579)
      BMJ. 2016 Nov 23;355:i5953. (PMID: 27881363)
      Am J Epidemiol. 2018 Jul 1;187(7):1530-1538. (PMID: 29584812)
      Diabetes Care. 2013 Feb;36(2):328-35. (PMID: 23002083)
      Stroke. 2012 Oct;43(10):2551-5. (PMID: 22871677)
      Cardiovasc Diabetol. 2023 Feb 20;22(1):35. (PMID: 36804876)
      Eur J Epidemiol. 2021 Aug;36(8):767-768. (PMID: 34216355)
      J Surg Res. 2018 Mar;223:259-260. (PMID: 29198604)
      Am J Med. 2006 May;119(5):448.e1-19. (PMID: 16651058)
      Milbank Q. 2018 Dec;96(4):706-754. (PMID: 30537364)
      JAMA. 1994 Mar 16;271(11):840-4. (PMID: 8114238)
      N Engl J Med. 2014 Apr 17;370(16):1514-23. (PMID: 24738668)
      Lancet. 2009 Feb 28;373(9665):739-45. (PMID: 19249635)
      Cardiovasc Diabetol. 2021 Dec 7;20(1):230. (PMID: 34876114)
      Diabetes Care. 2019 Sep;42(9):1809-1815. (PMID: 31320445)
      JAMA Netw Open. 2022 Feb 1;5(2):e2147171. (PMID: 35129595)
    • Contributed Indexing:
      Keywords: New Zealand; atrial fibrillation; impaired glucose tolerance; type 2 diabetes
    • Publication Date:
      Date Created: 20230913 Date Completed: 20230930 Latest Revision: 20231005
    • Publication Date:
      20240829
    • Accession Number:
      PMC10547295
    • Accession Number:
      10.1161/JAHA.123.030159
    • Accession Number:
      37702092